NCT00070564
Clinical Trial Information
Trial Number: NCT00070564 (ClinicalTrials.gov)
Disease Type:
- Breast Neoplasm - Breast Cancer (Invasive)
Trial Title:
Phase III Trial of Continuous Schedule AC + G vs. Q 2 Week Schedule AC, Followed by Paclitaxel Given Either Every 2 Weeks or Weekly for 12 Weeks as Post-Operative Adjuvant Therapy in Node-Positive or High-Risk Node-Negative Breast Cancer
Study ID:
S0221
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
| Title | Description |
|---|---|
| NCT00070564-D2 | There are 2 datasets associated with this publication: NCT00070564-D1 and NCT00070564-D2. This dataset contains adverse event data from trial NCT00070564 to reproduce results in PMID 25422488. |
| NCT00070564-D1 | There are 2 datasets associated with this publication: NCT00070564-D1 and NCT00070564-D2. This dataset will allow users to reproduce analysis in determining the optimal dose and schedule of anthracycline and taxane administration as adjuvant therapy for early-stage breast cancer in PMID 25422488. |
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®